The comfort of care is moving home. According to Renub Research, the United States Home Infusion Therapy Market will grow from US$ 10.26 billion in 2024 to approximately US$ 20.59 billion by 2033, registering a CAGR of 8.05% between 2025 and 2033. This surge is propelled by the rising prevalence of chronic diseases, advances in home healthcare technologies, and a growing preference for cost-effective, patient-centered treatment over prolonged hospital stays.

For complete analysis and forecasts, visit the full report: United States Home Infusion Therapy Market Size & Forecast 2025-2033.

The Shift from Hospital to Home – A Major Healthcare Transformation

Home infusion therapy involves the administration of medications, nutrients, or fluids intravenously in the patient’s home, supervised by trained healthcare professionals. It is becoming an essential part of the U.S. healthcare landscape as health systems focus on lowering costs, reducing hospital-acquired infections, and improving patient comfort.

Request sample Report:https://www.renub.com/request-sample-page.php?gturl=united-states-home-infusion-market-p.php

Key Growth Drivers in the U.S. Home Infusion Therapy Market

1. Rising Burden of Chronic Diseases
2. The U.S. is witnessing an unprecedented rise in chronic illnesses such as diabetes, cancer, heart disease, and immune disorders. According to the CDC, 6 in 10 U.S. adults live with at least one chronic disease, driving demand for long-term infusion treatments.
3. Technological Advancements
4. Portable infusion pumps, wireless monitoring, and telehealth integration have transformed how patients receive infusion care, allowing for real-time monitoring and adjustments without hospital visits.
5. Cost-Effectiveness and Insurance Support
6. Home-based infusion therapy is 30–60% more cost-effective than in-hospital treatment, and insurance providers increasingly cover these services due to cost savings and improved patient outcomes.
7. Growing Geriatric Population
8. With the U.S. population aged 65 and older projected to reach 80 million by 2040, demand for home healthcare services, including infusion therapy, is surging.

Market Segmentation – By Application

The report segments the U.S. home infusion therapy market into:

1. Anti-Infective – Largest share, driven by high demand for intravenous antibiotics to treat severe infections at home.
2. Endocrinology – Covers hormone treatments, including insulin therapy.
3. Hydration Therapy – Increasingly used for chronic dehydration and recovery from illness.
4. Chemotherapy – Allows cancer patients to receive treatments without frequent hospital visits.
5. Enteral Nutrition – Nutrient delivery via feeding tubes for patients unable to eat normally.
6. Parenteral Nutrition – Intravenous nutrition for those with digestive system impairments.
7. Specialty Pharmaceuticals – Includes advanced biologics for conditions like multiple sclerosis.
8. Others – Pain management and immune globulin therapies.

Market Segmentation – By Product

The product landscape includes:

• Infusion Pumps – Technologically advanced, portable, and programmable devices dominate the market.

• Intravenous (IV) Sets – Essential for fluid and medication administration.

• Cannulas – Key component for intravenous access.

• Needles – Used across multiple infusion procedures.

Why Patients Prefer Home Infusion Therapy

• Comfort and Familiarity – Receiving treatment at home reduces stress and disruption to daily life.

• Reduced Infection Risks – Lower exposure to hospital-acquired infections.

• Personalized Care – More time and attention from home healthcare professionals.

• Flexibility – Ability to schedule treatments around personal routines.

Challenges Facing the U.S. Home Infusion Therapy Market

While growth is strong, the market faces certain challenges:

• Workforce Shortages – Limited availability of skilled home infusion nurses.

• Reimbursement Variability – Coverage differs between private insurers and Medicare/Medicaid.

• Technology Costs – Advanced devices can be expensive for smaller providers.

• Patient Compliance – Requires education and self-management for optimal results.

Regional Dynamics Within the United States

• Northeast – Strong adoption due to advanced healthcare infrastructure.

• Midwest – Growing home healthcare networks supporting rural populations.

• South – Increasing demand due to higher chronic disease prevalence.

• West – Significant uptake driven by tech-enabled healthcare solutions.

Leading Players in the U.S. Home Infusion Therapy Market

Major companies in the sector include:

• Option Care Health

• Coram CVS Specialty Infusion Services

• BriovaRx (UnitedHealth Group)

• Fresenius Kabi USA

• ICU Medical, Inc.

• Smiths Medical

• B. Braun Medical Inc.

These players are expanding services, integrating telehealth, and investing in training to meet growing demand.

Future Outlook – Home Infusion Therapy as a Healthcare Norm

By 2033, home infusion therapy is expected to become a mainstay in chronic disease management, supported by telemedicine, AI-powered patient monitoring, and value-based care models. As more patients embrace at-home treatments, the sector will continue to grow in both size and sophistication.

New Publish Report:

https://www.openpr.com/news/4139507/global-household-cleaning-products-market-to-reach-usd-61-50

https://www.openpr.com/news/4139500/europe-biopsy-devices-market-to-surpass-us-1-13-billion-by-2033

https://www.openpr.com/news/4139495/anti-venom-market-to-reach-us-2-07-billion-by-2033-driven

10 Frequently Asked Questions (FAQs)

1. What is the projected size of the U.S. Home Infusion Therapy Market by 2033?
2. Approximately US$ 20.59 billion.
3. What was the market size in 2024?
4. Around US$ 10.26 billion.
5. What is the expected CAGR for 2025–2033?
6. A CAGR of 8.05%.
7. Which application holds the largest market share?
8. Anti-infective therapies lead the market.
9. What products dominate the market?
10. Infusion pumps hold the largest share due to portability and advanced features.
11. What is driving market growth?
12. Rising chronic diseases, aging population, technological innovations, and cost savings.
13. What are the main challenges?
14. Shortage of skilled professionals and variability in reimbursement policies.
15. How does home infusion therapy save costs?
16. It can be 30–60% cheaper than hospital-based care.
17. Who are the major market players?
18. Option Care Health, Coram CVS, BriovaRx, Fresenius Kabi USA, ICU Medical, and others.
19. Will technology play a bigger role in the future?
20. Yes, AI, telehealth, and smart devices will significantly enhance patient monitoring and care delivery.

About Renub Research

Renub Research is a Market Research and Consulting Company with more than 15 years of experience, especially in international Business-to-Business Research, Surveys, and Consulting. We provide a wide range of business research solutions that help companies make better business decisions.

We partner with clients across all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele includes key players in Healthcare, Travel & Tourism, Food & Beverages, Power & Energy, Information Technology, Telecom & Internet, Chemicals, Logistics & Automotive, Consumer Goods & Retail, Building & Construction, and Agriculture.

Our core team comprises experienced professionals with graduate, postgraduate, and Ph.D. qualifications in Finance, Marketing, Human Resources, Bio-Technology, Medicine, Information Technology, Environmental Science, and more.

Media Contact

Company Name: Renub Research

Contact Person: Rajat Gupta, Marketing Manager

Phone No: +91-120-421-9822 (IND) | +1-478-202-3244 (USA)

Email: rajat@renub.com